A robust and stable business environment is crucial for driving innovation and encouraging investment in the UK. We work closely with the national and devolved governments, industry bodies, and regulatory authorities to create conditions that foster growth in life sciences and the wider economy. This includes ensuring that the UK can be globally competitive in developing and manufacturing innovative medicines.

Patients are at the heart of everything we do. At AstraZeneca, we believe every patient deserves timely and equitable access to innovative treatments that improve care. To achieve this, we collaborate with NHS bodies, public organisations, and government officials to identify and address barriers to access and adoption. Additionally, we work with partners to develop scalable solutions that enhance the healthcare system's capacity to deliver innovative medicines.